Schedule 13G ownership disclosure

HEPION PHARMACEUTICALS INC

Security class unavailable · CUSIP: 426897104

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
335,745
Percent of class
1.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-21-000334
Form type
SC 13G/A
Filer
Empery Asset Management, LP
CIK
CIK 1469336
Filed
Jan 20, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub